NDC 43063-801 – Guaifenesin DM
Guaifenesin 400 mg/1; Dextromethorphan Hydrobromide 20 mg/1 · Tablet · Oral
Product NDC43063-801
Product details
- Brand name
- Guaifenesin DM
- Generic name
- Guaifenesin And Dextromethorphan Hydrobromide
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- April 2, 2018
- Marketing end
- November 30, 2027
- Pharmacologic class
- Expectorant; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Guaifenesin 400 mg/1
- Dextromethorphan Hydrobromide 20 mg/1
Uses, dosage, side effects and warnings for Guaifenesin DM →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 43063-801-30 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-801-30) | Apr 2, 2018 |
| 43063-801-60 | 60 TABLET in 1 BOTTLE, PLASTIC (43063-801-60) | Apr 2, 2018 |
| 43063-801-90 | 90 TABLET in 1 BOTTLE, PLASTIC (43063-801-90) | Apr 2, 2018 |
Other Guaifenesin DM products
- 60687-817 Guaifenesin 100 mg/5mL; Dextromethorphan 10 mg/5mL · Syrup · American Health Packaging
- 60687-828 Guaifenesin 200 mg/10mL; Dextromethorphan 20 mg/10mL · Syrup · American Health Packaging
- 55154-5783 Guaifenesin 100 mg/5mL; Dextromethorphan 10 mg/5mL · Syrup · Cardinal Health 107, LLC
- 55154-5785 Guaifenesin 100 mg/5mL; Dextromethorphan 10 mg/5mL · Syrup · Cardinal Health 107, LLC
- 71800-057 Dextromethorphan Hydrobromide 10 mg/5mL; Guaifenesin 100 mg/5mL · Liquid · Innovida Pharmaeutique Corporation
- 0121-0638 Guaifenesin 100 mg/5mL; Dextromethorphan 10 mg/5mL · Syrup · PAI Holdings, LLC dba PAI Pharma
- 0121-1276 Guaifenesin 200 mg/10mL; Dextromethorphan 20 mg/10mL · Syrup · PAI Holdings, LLC dba PAI Pharma